Brian C. Carr

Versant Diagnostics is a company founded in 2021 by Ven Aduana, Jim Billington, and Brian Carr. The company is based in Oak Brook, IL and has subsidiaries in the United States. Versant Diagnostics is focused on anatomic pathology, precision medicine, and the digital transformation of the industry. The company combines technological advancements in healthcare with the most skilled and diverse set of subspecialty pathologists to provide superior service for hospitals and physician practices. Versant Diagnostics aims to become the nation's largest independent physician services platform focused on anatomic pathology by consolidating the most advanced technology with the most skilled pathologists across a diverse set of specialties to provide superior, one-stop service to hospitals and independent practices. Jim Billington has been the CEO since incorporation.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Versant Diagnostics is a company founded in 2021 by Ven Aduana, Jim Billington, and Brian Carr. The company is based in Oak Brook, IL and has subsidiaries in the United States. Versant Diagnostics is focused on anatomic pathology, precision medicine, and the digital transformation of the industry. The company combines technological advancements in healthcare with the most skilled and diverse set of subspecialty pathologists to provide superior service for hospitals and physician practices. Versant Diagnostics aims to become the nation's largest independent physician services platform focused on anatomic pathology by consolidating the most advanced technology with the most skilled pathologists across a diverse set of specialties to provide superior, one-stop service to hospitals and independent practices. Jim Billington has been the CEO since incorporation.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Part of Inotiv, Inc., Protypia, Inc. provides targeted tissue-based protein and peptide mass spectrometry solutions. The company is based in Nashville, TN. The company was founded in 2017 by Daniel C. Liebler. Daniel C. Liebler has been the CEO since 2017. Protypia was acquired by Inotiv, Inc. on July 07, 2022 for $11 million.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Versant Diagnostics is a company founded in 2021 by Ven Aduana, Jim Billington, and Brian Carr. The company is based in Oak Brook, IL and has subsidiaries in the United States. Versant Diagnostics is focused on anatomic pathology, precision medicine, and the digital transformation of the industry. The company combines technological advancements in healthcare with the most skilled and diverse set of subspecialty pathologists to provide superior service for hospitals and physician practices. Versant Diagnostics aims to become the nation's largest independent physician services platform focused on anatomic pathology by consolidating the most advanced technology with the most skilled pathologists across a diverse set of specialties to provide superior, one-stop service to hospitals and independent practices. Jim Billington has been the CEO since incorporation.

Part of Inotiv, Inc., Protypia, Inc. provides targeted tissue-based protein and peptide mass spectrometry solutions. The company is based in Nashville, TN. The company was founded in 2017 by Daniel C. Liebler. Daniel C. Liebler has been the CEO since 2017. Protypia was acquired by Inotiv, Inc. on July 07, 2022 for $11 million.